India Drug Lobbyists Argue Against EU Directive Requiring API Documents
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers are opposing a European Commission directive set to take effect in a year that would require shipments of active pharmaceutical ingredients from India to certify they meet EU standards.